Prescription Drug Prices

Last week, President Donald Trump grabbed his Sharpie and signed an executive order to tackle the sky-high prescription drug prices in the U.S. The plan? A “Most Favored Nation” (MFN) pricing model that aligns U.S. drug costs with those of other countries. 

Sound familiar? Trump tried this during his first term, but the courts rejected it, and Biden hit the ‘undo’ button.

Here’s the lowdown on why Trump is back at it, what’s at stake, and whether this bold move will stick.